Understanding platinum-induced ototoxicity
- PMID: 23769626
- DOI: 10.1016/j.tips.2013.05.006
Understanding platinum-induced ototoxicity
Abstract
Childhood cancer survival rates are now nearly 80% in more developed European countries because of improved therapies and better supportive care. Platinum chemotherapy drugs, such as cisplatin and carboplatin, are the cornerstone of many effective therapeutic protocols for childhood cancer. However, the antitumor efficacy of cisplatin and carboplatin comes at the cost of ototoxicity, which affects at least 60% of pediatric patients. Although ototoxicity is not life threatening, it can have debilitating effects on patients' quality of life. Recently, many initiatives have been launched with the ultimate goal of reducing cisplatin and high-dose carboplatin ototoxicity without compromising antitumor efficacy. This review addresses the incidence of platinum ototoxicity and its clinical presentation, time course, and early diagnostic evaluation. Genetic and non-genetic risk factors for platinum-associated ototoxicity, and their predictive value, are discussed. Recent developments in the prevention of platinum ototoxicity are also summarized.
Keywords: adverse effects; high frequency audiometry; organoplatinum compounds; pharmacogenetics; prevention; risk factors.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.Pediatr Blood Cancer. 2014 Nov;61(11):2012-7. doi: 10.1002/pbc.25123. Epub 2014 Jun 29. Pediatr Blood Cancer. 2014. PMID: 24976616
-
Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.Eur J Cancer. 2020 Oct;138:212-224. doi: 10.1016/j.ejca.2020.07.019. Epub 2020 Sep 6. Eur J Cancer. 2020. PMID: 32905960
-
[Cisplatin and carboplatin-induced ototoxicity in children: clinical aspects and perspectives for prevention].Acta Otorhinolaryngol Ital. 2002 Feb;22(1):14-8. Acta Otorhinolaryngol Ital. 2002. PMID: 12236007 Italian.
-
[About side effects of platinum drugs].Postepy Hig Med Dosw. 2001;55(3):387-406. Postepy Hig Med Dosw. 2001. PMID: 11505639 Review. Polish.
-
Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria.Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1187-1196. doi: 10.1007/s00405-016-4117-z. Epub 2016 May 31. Eur Arch Otorhinolaryngol. 2017. PMID: 27245751 Review.
Cited by
-
Inexhaustible hair-cell regeneration in young and aged zebrafish.Biol Open. 2015 May 22;4(7):903-9. doi: 10.1242/bio.012112. Biol Open. 2015. PMID: 26002931 Free PMC article.
-
Cochlear protection against cisplatin by viral transfection of X-linked inhibitor of apoptosis protein across round window membrane.Gene Ther. 2015 Jul;22(7):546-52. doi: 10.1038/gt.2015.22. Epub 2015 Mar 26. Gene Ther. 2015. PMID: 25809464
-
Sirtuin 1 and Autophagy Attenuate Cisplatin-Induced Hair Cell Death in the Mouse Cochlea and Zebrafish Lateral Line.Front Cell Neurosci. 2019 Jan 14;12:515. doi: 10.3389/fncel.2018.00515. eCollection 2018. Front Cell Neurosci. 2019. PMID: 30692914 Free PMC article.
-
A Review of Cisplatin-Associated Ototoxicity.Semin Hear. 2019 May;40(2):108-121. doi: 10.1055/s-0039-1684041. Epub 2019 Apr 26. Semin Hear. 2019. PMID: 31036989 Free PMC article. Review.
-
Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity.Int J Mol Sci. 2020 May 15;21(10):3503. doi: 10.3390/ijms21103503. Int J Mol Sci. 2020. PMID: 32429117 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical